1. Home
  2. NYXH vs CAST Comparison

NYXH vs CAST Comparison

Compare NYXH & CAST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.50

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

CAST

FreeCast Inc. Class A Common Stock

N/A

Current Price

$4.46

Market Cap

194.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NYXH
CAST
Founded
2009
2011
Country
Belgium
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
190.6M
194.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NYXH
CAST
Price
$3.50
$4.46
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$11.25
N/A
AVG Volume (30 Days)
53.1K
194.4K
Earning Date
05-13-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$214.32
N/A
Revenue Next Year
$124.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$1.88
52 Week High
$8.64
$4.90

Technical Indicators

Market Signals
Indicator
NYXH
CAST
Relative Strength Index (RSI) 53.12 66.44
Support Level N/A $1.88
Resistance Level $5.02 $4.90
Average True Range (ATR) 0.17 0.84
MACD 0.07 0.15
Stochastic Oscillator 95.32 86.75

Price Performance

Historical Comparison
NYXH
CAST

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: